ARWR - Arrowhead Pharmaceuticals Inc. (ARWR) CEO Christopher Anzalone on Q2 2022 Results - Earnings Call Transcript
Arrowhead Pharmaceuticals, Inc. (ARWR) Q2 2022 Earnings Conference Call May 10, 2022, 04:30 PM ET Company Participants Vince Anzalone - VP, IR Christopher Anzalone - President and CEO Javier San Martin - Chief Medical Officer Ken Myszkowski - CFO James Hamilton - SVP, Discovery and Translational Medicine James Hassard - Chief Commercial Officer Conference Call Participants Maury Raycroft - Jeffries Luca Issi - RBC Capital Ellie Merle - UBS Joel Beatty - Baird Patrick Trucchio - HC Wainwright Mayank Mamtani - B. Riley Securities Keay Nakae - Chardan Mani Foroohar - SVB Securities Presentation Operator Ladies and gentlemen, welcome to the Arrowhead Pharmaceuticals Conference Call. Throughout today's recorded presentation, all participants will be in a listen-only mode. After the presentation, there will be an opportunity to ask questions. I will now hand the conference call over to Vince Anzalone, Vice President of Finance and Investor Relations for Arrowhead. Please go
For further details see:
Arrowhead Pharmaceuticals, Inc. (ARWR) CEO Christopher Anzalone on Q2 2022 Results - Earnings Call Transcript